The Cancer Letter

Inside information on cancer research and drug development

Fox Chase gets three-year no-cost extension as director Fisher departs

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print
BYLINE
IN THIS ISSUE
BYLINEDOWNLOAD PDFTABLE OF CONTENTS

God did not intend directors of NCI-designated cancer centers to last in their jobs forever.

They move on to become deans, vice deans, associate vice deans and such. Some return to the lab, clinic, classroom, or all three. Others genuinely retire, or retire in place, with emeritus titles and sets of golf clubs. Still others move on to run other cancer centers or take jobs in the industry or nonprofits. A few become NCI directors.

Very few are asked to turn in their company cell phones and laptops, lose email access, and receive immediate assistance with packing their offices. A few days ago, Richard I. Fisher, president, CEO, and director of Fox Chase Cancer Center, was relieved of his duties at the institution he ran since 2013 (The Cancer Letter, Dec. 7, 2012; May 15, 2015).

Temple University Health System, which owns Fox Chase, announced Fisher’s departure on Nov. 24. 

To access this subscriber-only content please log in or renew your subscription.

Looking for IP Login? Our IP Login system is now automatic. If your institution has a site license, please log in from on site or via your VPN to access this content.

Login Subscribe
Byline
Paul Goldberg
Editor & Publisher
Table of Contents

YOU MAY BE INTERESTED IN

Guest Editorial

Call to action: To address Black cancer disparities, focus on research prioritization and clinical studies inclusion
Minority Cancer Awareness Week

People of African ancestry (Black/African American) have some of the worst cancer incidence and greatest mortality, compared to white and other racial and ethnic populations in the U.S. On average, Black persons are 1.5 times more likely to have cancer and >2X more likely to die from cancer compared to whites. xxx:more
By Kimlin Tam Ashing, Nadine J. Barrett, Kim F. Rhoads, Folakemi T. Odedina, Hayley S. Thompson and Camille C. R. Ragin
Conversation with The Cancer Letter

OHSU Knight Cancer Institute splits leadership role in two: (1) CEO and (2) center director
Eight NCI-designated centers believe the top job is too big for one person

A previous version of this story stated incorrectly that seven institutions split the role of director in two. The original list omitted Fox Chase Cancer Center. Read more.Slowly, over the past two decades, at least eight major cancer centers have changed their organizational structures, splitting the job of the cancer center director into two boxes on the org chart: (1) the chief executive, and (2) the scientist in charge of the NCI Cancer Center Support Grant.
By Paul Goldberg
Byline
Paul Goldberg
Editor & Publisher
Table of Contents

Login

Looking for IP Login?